Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Glaxosmithkline Plc (NY: GSK )

38.88 USD +0.52 (+1.34%)
Streaming Delayed Price Updated: 2:41 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Glaxosmithkline Plc

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ABT FLGT Market News
From Benzinga
Cramer Weighs In On Zoom Video, World Wrestling Entertainment And More
On CNBC's "Mad Money Lightning Round," Jim Cramer saidhe would rather own Walmart Inc (NYSE: WMT) or Target ... 
Tags mad money Lightning Round Jim Cramer GSK
From Benzinga
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Biotech stocks advanced in the week ended July 10 amid mixed news emerging out of the sector. FDA approved a few drugs, including Endo International PLC's cellulite treatment, while Merck & Co. & Eisai... 
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
The Week Ahead In Biotech: J&J Kickstarts Pharma Earnings, Repare Therapeutics IPO
Biotech stocks advanced in the week ended July 10 amid mixed news flow emerging out of the sector. FDA approved a few drugs, ... 
Tags MNK Trading Ideas Penny Stocks
From Benzinga
GlaxoSmithKline Inks New COVID-19 Vaccine Research Pact
Medicago is using GlaxoSmithKline's vaccine adjuvant in its clinical-stage COVID-19 vaccine. 
Tags Market News GSK SNY
From Motley Fool
We Are All Jains Now
GlaxoSmithKline is likely to secure $624.5 bn for supplying Britain with a COVID-19 jab. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Sum Up The Parts: FVD Could Be Worth $34
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Is Dynavax Technologies Stock a Buy?
This stock has the potential to break new highs with its key hepatitis B vaccine and emerging vaccine-adjuvant platform for COVID-19 vaccines. 
Tags DVAX BLK PGNX
From Motley Fool
GSK August 14th Options Begin Trading
Investors in GlaxoSmithKline plc (GSK) saw new options become available today, for the August 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GSK options... 
Tags Stocks
From Market News Video
Pedal to the Metal Leads to Record Rebound
Like a race car pushing the pedal to the metal, the stock market sped to its best quarterly stock market gains in decades. The +20% rebound in the 2nd quarter S&P 500 index was the best result achieved... 
Tags Consumer Goods Pharma/Biotech Healthcare
From Blogs - TalkMarkets
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
The busy calendar of June proved positive for drug approvals, with most scheduled events producing positive outcomes. New molecular ... 
Tags VIE ALXN Trading Ideas
From Benzinga
Cramer Welcomes 3 Stocks To His COVID-19 Index, Kicks Out 3 Others
CNBC "Mad Money" host Jim Cramer has been managing a mock index of 100 stocks that stand to benefit financially from the ... 
Tags Trading Ideas Covid/19 vaccine
From Benzinga
Stimulus hints help drive a rally for U.K. stocks
Hopes for more stimulus were a big driver behind gains for London stocks on Friday, allowing investors to ignore a record number of COVID-19 outbreaks across several U.S. states. Shares of Tesco shook... 
Tags UK:ULVR Commodities UL
From MarketWatch
European stocks in the red as investors fret about rising U.S. Covid-19 infections
European stocks traded lower on Wednesday, as markets struggled to gain traction against a backdrop of rising coronavirus cases in the U.S. Technology stocks were a bright spot after another record... 
Tags XX:SXXP Health/Care Automobiles
From MarketWatch
Sanofi Accelerates Coronavirus Vaccine Timeline, Says Approval Could Come In First Half Of 2021
Sanofi SA (NASDAQ: SNY), which isin the race to develop a vaccine for SARS-CoV-2, which causes COVID-19, is unveiling an ... 
Tags General News Coronavirus
From Benzinga
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks ... 
Tags TRVN EVFM AGLE
From Benzinga
3 Healthcare Stocks That Surged Last Week
Here's what pushed up shares of the highest-flying healthcare stocks. 
Tags QDEL IDYA Market News
From Motley Fool
Everything You Need to Know About At-Home Testing Start-Ups 23andMe, Ancestry, and Everlywell
The direct-to-consumer health testing market is still nascent, but these companies are leading the way. 
Tags GSK Market News DGX
From Motley Fool
How The Coronavirus Pandemic Could Give Rise To A New Type Of Vaccine
The race for a coronavirus vaccine is giving biotech companies like Moderna, BioNTech and Translate Bio the chance to prove a relatively new technology known as messenger RNA vaccines. 
From Investor's Business Daily
UPDATE 2-Clover launches sixth Chinese COVID-19 vaccine trial
* Clover's vaccine will test GSK, Dynavax boosters in 150 adults 
Tags companyNews
From Reuters: Company News
Is GlaxoSmithKline a Great Dividend Stock?
The pharmaceutical giant recently cut its dividend, but it still pays a better yield than most in the industry. 
Tags Market News GSK PFE
From Motley Fool
UPDATE 1-Sixth trial of potential Chinese COVID-19 shot begins with GSK, Dynavax mix
A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday an early-stage study of its candidate was underway with vaccine boosters... 
Tags companyNews
From Reuters: Company News
China's Clover begins human trials of COVID-19 shot with GSK, Dynavax boosters
A potential coronavirus vaccine being developed by China's Clover Biopharmaceuticals using GlaxoSmithKline's vaccine booster is now in early-stage testing in humans, the companies said on Friday. 
Tags companyNews
From Reuters: Company News
Here's Why IDEAYA Biosciences Lost Nearly 23% Today
The development-stage drug developer is selling common stock to raise cash. It's a wise move. 
Tags GSK Market News
From Motley Fool
Where Will Novavax Be in 5 Years?
The future looks very bullish for this vaccine specialist. 
Tags PFE MRNA Market News
From Motley Fool
The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
Here's a roundup of top developments in the biotech space over the last 24 hour. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FDA EVOK Health Care
From Benzinga
UPDATE 3-France gives its drugs industry a shot in the arm to tackle pandemic
* Macron says to repatriate some drugs production (Adds details on Sanofi investment, context) 
Tags companyNews
From Reuters: Company News
UPDATE 2-France gives its drugs industry a shot in the arm to tackle pandemic
* Macron says to repatriate some drugs production (Adds more Macron comments, background) 
Tags companyNews
From Reuters: Company News
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adverum's New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BNR ONCY Trading Ideas
From Benzinga
UPDATE 1 -France gives its drugs industry a shot in the arm to tackle pandemic
France's president and top drugmaker announced plans on Tuesday to bolster domestic production of medicines as countries scramble to strengthen their healthcare industries to counter the coronavirus... 
Tags companyNews
From Reuters: Company News
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.